Anterior segment ischemia following strabismus surgery in a young adult using gender-affirming estrogen hormone therapy

被引:1
|
作者
Al-Lozi, Amal [1 ]
Koo, Euna B. [1 ]
Lambert, Scott R. [1 ]
Levin, Marc H. [2 ]
Velez, Federico G. [3 ]
Do, Diana, V [1 ]
Shue, Ann [1 ,4 ]
机构
[1] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA USA
[2] Palo Alto Med Fdn, Dept Ophthalmol, Palo Alto, CA USA
[3] Univ Calif Los Angeles, Doheny Eye Inst, Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA USA
[4] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, 2452 Watson Ct, Palo Alto, CA 94303 USA
来源
JOURNAL OF AAPOS | 2023年 / 27卷 / 04期
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.jaapos.2023.05.004
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Well-known risk factors for anterior segment ischemia (ASI) following strabismus surgery include ipsilateral surgery on three or more rectus muscles, older age, and vasculopathy. ASI is rarely reported in young patients following uneventful strabismus surgery on two ipsilateral rectus muscles. We report a 30-year-old transgender female on long-term estrogen therapy who underwent strabismus surgery involving recessions of both lateral rectus muscles, the right inferior rectus muscle, and the left superior rectus muscle. The left eye developed severe ASI with hypotony maculopathy that was resistant to topical medications, oral steroids, anterior chamber reformation, and intravitreal steroid injection. Following phacoemulsification with intraocular lens and capsular tension ring insertion 1 year later, intraocular pressure and hypotony maculopathy improved.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 40 条
  • [31] Differences Between Transgender and Gender Diverse Adults in Michigan Currently Using Gender-Affirming Hormone Therapy and Nonusers Reporting Interest in Future Use
    Shires, Deirdre A.
    Kattari, Leonardo
    Hill, Haley
    Anderson, Kaston D.
    Misiolek, Brayden
    Kattari, Shanna K.
    LGBT HEALTH, 2024, 11 (06) : 446 - 454
  • [32] Absence of venous thromboembolism in transgender male to female patients following the gender-affirming procedure of facial feminization: a retrospective study of 236 patients using hormone therapy
    Price, Ryan K.
    Debryn, Deen
    Mukerji, Shivali
    Nurhussien, Lina
    Kim, Eugene
    ANESTHESIA AND ANALGESIA, 2021, 132 (5S_SUPPL): : 676 - 677
  • [33] The Effects of Perioperative Gender-affirming Hormone Therapy on Facial Feminization Surgery Adverse Events, Facial Features Addressed, and Esthetic Satisfaction: A Multimodal Analysis
    Laspro, Matteo
    Hoffman, Alexandra
    Chinta, Sachin
    Abdalla, Jasmina
    Tran, David
    Oh, Cheongeun
    Robinson, Isabel
    Rodriguez, Eduardo D.
    JOURNAL OF CRANIOFACIAL SURGERY, 2025, 36 (02) : 600 - 604
  • [34] Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study
    Miranda, Keila Turino
    Dumanski, Sandra M.
    Saad, Nathalie
    Inker, Lesley A.
    White, Christine A.
    Delanaye, Pierre
    Collister, David
    Greene, Dina N.
    Whitley, Cameron T.
    Harrison, Tyrone G.
    Rytz, Chantal L.
    Peace, Lindsay
    Sola, Darlene Y.
    Ahmed, Sofia B.
    KIDNEY INTERNATIONAL, 2024, 106 (04) : 753 - 756
  • [35] A mini-review of the evidence for cerebrovascular changes following gender-affirming hormone replacement therapy and a call for increased focus on cerebrovascular transgender health
    Wright, Melissa Emily
    Murphy, Kevin
    FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
  • [36] Short and long duration testosterone treatments induce reversable subfertility in female mice using a gestational model of gender-affirming hormone therapy
    Pfau, Daniel R.
    Cho, Evelyn
    Clark, Jamison G.
    Kruger, Robin E.
    Chan-Sui, Ruth K.
    Kinnear, Hadrian
    Dela Cruz, Cynthia
    Schwartz, Amanda R.
    Padmanabhan, Vasantha
    Shikanov, Ariella
    Moravek, Molly B.
    HUMAN REPRODUCTION, 2025,
  • [37] FACE-Q satisfaction following upper third facial gender-affirming surgery using custom bone-section guides
    Schmidt, M.
    Ramelli, E.
    Atlan, M.
    Cristofari, S.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2023, 52 (06) : 696 - 702
  • [38] Subcutaneous Testosterone Is Effective and Safe as Gender-Affirming Hormone Therapy in Transmasculine and Gender-Diverse Adolescents and Young Adults: A Single Center's 8-Year Experience
    Laurenzano, Sarah E.
    Newfield, Ron S.
    Lee, Euyhyun
    Marinkovic, Maja
    TRANSGENDER HEALTH, 2021, 6 (06) : 343 - 352
  • [39] TRANSGENDER AND GENDER DIVERSE YOUNG ADULTS TAKING LONG-TERM GENDER-AFFIRMING HORMONE THERAPY DO NOT HAVE ADVERSELY ELEVATED CAROTID STIFFNESS OR INTIMA-MEDIAL THICKNESS
    Pribish, Abby
    Moreau, Kerrie
    Dubose, Lyndsey
    Thurman, Brook L.
    Babcock, Matthew
    Cornier, Marc
    Wierman, Margaret
    Rothman, Micol
    Hammond, Daniel
    Mancuso, Mary
    Gebregzabheir, Amanuail
    Sammel, Mary
    Iwamoto, Sean
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1736 - 1736
  • [40] Transcriptomic analysis of peripheral blood mononuclear cells reveals immune and metabolic pathways associated with both puberty-blockade and gender-affirming sex hormone therapy in young transgender individuals
    Cross, Heather
    Peckham, Hannah
    Peng, Junjie
    Radziszewska, Ania
    Butler, Gary
    Jury, Elizabeth
    Rosser, Elizabeth
    Robinson, George A.
    Ciurtin, Coziana
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 525 - 526